{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Compounds as inhibitors of hepatitis C virus NS3 serine protease", "item": "https://www.patentleaderboard.com/patent/7192957"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds as inhibitors of hepatitis C virus NS3 serine protease

Compounds as inhibitors of hepatitis C virus NS3 serine protease

US Patent 7192957 · Granted Mar 20, 2007

Estimated economic value: $49,693,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Matriptase 2 inhibitors and uses thereof2025
Pyrrolidine orexin receptor agonists2025
Anti-influenza virus pyrimidine derivatives2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Cyclobutyl pyrazolopyrimidine PDE9 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors a2024
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023
Anti-influenza virus pyrimidine derivative2023
Cyclic di-nucleotide compounds as sting agonists2023